Speakers
Yilmaz Biter
Founder & Director
BioPitch
Bernd Boidol, Ph. D.
CEO
Proxygen
Vanessa Carle, Ph.D.
Principal
Forbion
Peter Carmeliet, M.D., Ph.D.
Professor
KU Leuven
Karen Chan, Ph.D.
Senior Director, Lilly Gateway Labs
Eli Lilly
Renato Chirivi, Ph.D.
Cofounder & CTO
Citryll
Emer Cooke
Executive Director
EMA
João Eurico Cabral da Fonseca, M.D., Ph.D.
Dean, School of Medicine
University of Lisbon
Ruben de Francisco, Ph.D.
Founder & CEO
Onera Health
Lindsay Edwards, D.Phil.
CTO
Relation Therapeutics
Mostafa Elsayed
Cofounder & CEO
Automata
Mathias Falcenberg, Ph.D.
Venture Partner
V-Bio Ventures
Mark Fish
VP and General Manager
Thermo Fisher Scientific
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Arthur Franken
General Partner
Gilde Healthcare
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
John Kastelein, M.D., Ph.D.
Founder & CSO
NewAmsterdam Pharma
Cillian King, Ph.D.
Partner
EQT Life Sciences
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
John Lepore, M.D.
President & CEO
ProFound Therapeutics
Jing Liang, Ph.D.
Managing Partner
Umbrex
Theresa Liectenstein, Ph.D.
Partner
4BIO Capital
Luca Lotta, M.D., Ph.D.
VP and Chief Translational Genetics Officer, Regeneron Genetics Center
Regeneron
Karen Massey
CEO
argenx
Christel Menet, Ph.D.
Chief Scientific Officer
Confo Therapeutics
Geert-Jan Mulder, M.D.
Managing Partner
Forbion
Paul Nioi, Ph.D.
SVP, Research
Alnylam Pharmaceuticals
Luke O'Neill, Ph.D.
Professor of Biochemistry, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute
Trinity College
Henrik Oerum, Ph.D.
Co-Founder & CSO
WinQure Medicine
Jing Pan, M.D., Ph.D.
Chief Physician
Institute of Hematology & Blood Diseases Hospital, Tianjin, China
Pieter Reitsma, Ph.D.
Founder, VarmX & Professor Emeritus
Leiden University Medical Center
Jane Rhodes, Ph.D.
CEO
AstronauTx
Giovanni Rizzo, Ph.D.
Partner
Indaco Venture Partners
William Robinson, M.D., Ph.D.
Professor
Stanford University
James Sabry, M.D., Ph.D.
EVP & Chief Business Officer
BioMarin
Sriram Sathy, Ph.D.
Chief Scientific Officer
Airna
Oskar Slotboom
Managing Partner
BioGeneration Ventures (BGV)
Jan Steyaert, Ph.D.
Director of VIB-VUB Center of Structural Biology, Professor
Vrije Universiteit Brussel
Chantal Swan, Ph.D.
Executive Search Consultant, Global Healthcare Practice
Russell Reynolds
Paul Peter Tak, M.D., Ph.D.
President & CEO
Candel Therapeutics
Christina Takke, Ph.D.
Managing Partner
V-Bio Ventures
Leen Thielemans, Ph.D.
Managing Partner and Chief Scientific Officer
2 Bridge
Diana Torgersen, D.Phil.
Head, Innovation Ecosystem Integration
Organon
Ben Turner
Director
Lilly Ventures
Magnus Walter, D.Phil.
Chief Technology Officer
Monte Rosa Therapeutics
Dan Zhang, M.D.
Chief Scientific Officer, Peking Union Innovation Hub & Co-Chairman of
Hillgene Biopharma
Hejian Zou, M.D., Ph.D.
Chief Physician & Professor, Department of Rheumatology & Immunology
Huashan Hospital, Fudan University, Shanghai, China